TDOC vs. GH, RDNT, BTSG, SHC, PRVA, SGRY, CON, LFST, VCYT, and ARDT
Should you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.
Teladoc Health vs.
Teladoc Health (NYSE:TDOC) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.
Teladoc Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.
76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Teladoc Health received 380 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.76% of users gave Guardant Health an outperform vote while only 62.61% of users gave Teladoc Health an outperform vote.
Teladoc Health has a net margin of -37.91% compared to Guardant Health's net margin of -59.05%. Teladoc Health's return on equity of -10.06% beat Guardant Health's return on equity.
In the previous week, Guardant Health had 6 more articles in the media than Teladoc Health. MarketBeat recorded 18 mentions for Guardant Health and 12 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 1.32 beat Guardant Health's score of 1.23 indicating that Teladoc Health is being referred to more favorably in the media.
Teladoc Health has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500.
Teladoc Health currently has a consensus target price of $9.71, suggesting a potential upside of 38.99%. Guardant Health has a consensus target price of $52.32, suggesting a potential upside of 41.06%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Teladoc Health.
Summary
Guardant Health beats Teladoc Health on 10 of the 19 factors compared between the two stocks.
Get Teladoc Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Teladoc Health Competitors List
Related Companies and Tools
This page (NYSE:TDOC) was last updated on 5/22/2025 by MarketBeat.com Staff
